\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ had\\ significant\\ pain\\ to\\ palpation\\ of\\ the\\ left\\ knee\\ and\\ on\\ weightbearing\\.\\ \\ she\\ had\\ an\\ elevated\\ wbc\\ with\\ a\\ left\\ shift\\ and\\ eleveated\\ esr\\ and\\ c\\-reactive\\ protein\\.\\ a\\ joint\\ aspirate\\ of\\ the\\ left\\ knee\\ revealed\\ polymorphonucleated\\ and\\ mononucleated\\ white\\ blood\\ cells\\.\ \(0\)\
\-\ systemic\\ antibiotics\\ \\(vancomycin\\)\\ and\\ surgical\\ debridement\ \(0\)\
\-\ 1\\)\\ anteroposterior\\ radiograph\\ of\\ the\\ left\\ knee\\ demonstrates\\ areas\\ of\\ osteolysis\\ in\\ the\\ distal\\ metaphysis\\ of\\ the\\ femur\\.\ \(0\)\
\-\ 2\\)\\ lateral\\ radiograph\\ of\\ the\\ left\\ knee\\ demonstrates\\ extensive\\ cortical\\ thickening\\ \\ with\\ foci\\ of\\ osteolysis\\ in\\ the\\ visualized\\ distal\\ femur\\ and\\ some\\ deformity\\ of\\ the\\ femur\\ most\\ marked\\ in\\ the\\ distal\\ metadiaphysis\\ and\\ the\\ medial\\ femoral\\ condyle\ \(0\)\
\-\ 3\\)\\ 3\\-phase\\ methylene\\ diphosphonate\\ \\(mdp\\)\\ 99\\-m\\ bone\\ scintigraphy\\ demonstrates\\ increased\\ radiopharmaceutical\\ uptake\\ in\\ the\\ distal\\ left\\ femur\\.\\ \\ the\\ 20\\-hour\\ delayed\\ fused\\ images\\ \\(99m\\ tc\\-mdp\\ with\\ 111\\-in\\-wbc\\)\\ showed\\ concordant\\ dual\\ tracer\\ accumulation\\ in\\ the\\ distal\\ left\\ femur\\ consistent\\ with\\ osteomyelitis\\.\ \(0\)\
\-\ 4\\)\\ axial\\ ct\\ of\\ the\\ left\\ knee\\ with\\ bone\\ windows\\ demonstrates\\ sclerotic\\ medullary\\ and\\ cortical\\ changes\\ of\\ the\\ left\\ mid\\ and\\ distal\\ femur\\ with\\ cortical\\ lucencies\\ and\\ acute\\ nonfatty\\ medullary\\ inflammatory\\ changes\\.\\ \\ an\\ osseous\\ sequestrum\\ is\\ present\\ in\\ the\\ distal\\ posterior\\ femur\\.\\ \\ at\\ the\\ level\\ of\\ the\\ condyles\\,\\ the\\ medullary\\ canal\\ communicates\\ through\\ a\\ cortical\\ defect\\ into\\ the\\ soft\\ tissues\\.\ \(0\)\
\-\ acute\\ on\\ chronic\\ osteomyelitis\ \(0\)\
\-\ post\\-traumatic\\ \\ changes\\ with\\ deformity\\ after\\ trauma\ \(0\)\
\-\ acute\\ on\\ chronic\\ osteomyelitis\ \(0\)\
\-\ post\\-traumatic\\ \\ changes\\ with\\ deformity\\ after\\ trauma\ \(0\)\
\-\ 82\\ y\\/o\\ female\\ with\\ significant\\ left\\ knee\\ pain\\ for\\ four\\ days\\;\\ the\\ patient\\ is\\ asplenic\\ and\\ has\\ a\\ prior\\ history\\ of\\ osteomyelitis\\ in\\ the\\ same\\ knee\\.\ \(1\)\
\-\ osteomyelitis\\,\\ an\\ infectious\\ process\\ that\\ produces\\ bony\\ destruction\\,\\ can\\ be\\ limited\\ to\\ a\\ single\\ area\\ of\\ bone\\ or\\ can\\ involve\\ multiple\\ areas\\,\\ including\\ the\\ marrow\\,\\ cortex\\,\\ periosteum\\,\\ and\\ surrounding\\ soft\\ tissue\\.\\ \\ osteomyelitis\\ may\\ spread\\ by\\ a\\ hematogenous\\ route\\,\\ from\\ a\\ contiguous\\ contaminated\\ source\\ \\(e\\.g\\.\\ following\\ trauma\\,\\ bone\\ surgery\\,\\ or\\ joint\\ replacement\\)\\,\\ or\\ be\\ a\\ complication\\ of\\ vascular\\ insufficiency\\ \\(predominantly\\ in\\ diabetic\\ patients\\)\\.\\ \\ staphylococcus\\ aureus\\ is\\ by\\ far\\ the\\ common\\ pathogen\\ causing\\ osteomyelitis\\.\\ \\ the\\ infection\\ may\\ be\\ acute\\ or\\ chronic\\;\\ acute\\ infections\\ tend\\ to\\ evolve\\ over\\ several\\ days\\ to\\ weeks\\.\\ acute\\ infection\\ may\\ resolve\\ with\\ appropriate\\ treatment\\.\\ osteomyelitis\\ that\\ is\\ untreated\\ or\\ insufficiently\\ treated\\ may\\ give\\ rise\\ to\\ a\\ chronic\\ infection\\ which\\ may\\ be\\ characterized\\ by\\ a\\ sequestrum\\ \\(necrotic\\ bone\\,\\ bacteria\\,\\ and\\ granulation\\ that\\ have\\ been\\ walled\\ off\\ by\\ new\\ reactive\\ bone\\ or\\ fibrous\\ tissue\\)\\.\\ \\ chronic\\ osteomyelitis\\ is\\ also\\ characterized\\ by\\ the\\ persistence\\ of\\ microorganisms\\,\\ low\\-grade\\ inflammation\\,\\ and\\ fistulous\\ tracts\\.\\ \\ recurrent\\ osteomyelitis\\ in\\ the\\ same\\ area\\ along\\ with\\ the\\ presence\\ of\\ fever\\ is\\ indicative\\ of\\ a\\ chronic\\ infection\\.\\ \\ the\\ diagnosis\\ of\\ osteomyelitis\\ is\\ based\\ on\\ clinical\\,\\ laboratory\\,\\ and\\ imaging\\ findings\\,\\ and\\ when\\ possible\\,\\ identification\\ of\\ the\\ offending\\ organism\\ by\\ blood\\ culture\\ or\\ direct\\ bone\\ biopsy\\.\ \(0\)\
\-\ plain\\ radiographs\\ should\\ be\\ the\\ first\\ imaging\\ modality\\ for\\ evaluating\\ osteomyelitis\\.\\ initially\\ they\\ may\\ be\\ normal\\ or\\ only\\ show\\ periosteal\\ reaction\\ and\\ soft\\ tissue\\ swelling\\.\\ \\ bone\\ destruction\\ \\(osteolytic\\ foci\\ on\\ the\\ radiographs\\)\\ may\\ not\\ be\\ visible\\ until\\ 10\\-21\\ days\\ after\\ the\\ infection\\ has\\ begun\\.\\ \\ with\\ chronicity\\,\\ reactive\\ osteosclerosis\\ as\\ well\\ as\\ areas\\ of\\ osteolysis\\ and\\ sequestra\\ and\\ involucra\\ may\\ occur\\.\\ differentiation\\ of\\ acute\\ osteomyelitis\\ from\\ inactive\\ chronic\\ osteomyelitis\\ can\\ be\\ difficult\\,\\ but\\ certain\\ indications\\ on\\ the\\ radiograph\\ aid\\ in\\ distinguishing\\ between\\ the\\ two\\,\\ including\\ a\\ change\\ from\\ a\\ previous\\ radiograph\\,\\ poorly\\ defined\\ areas\\ of\\ osteolysis\\,\\ \\ and\\ thin\\ and\\ linear\\ periostitis\\.\\ \\ although\\ ct\\ is\\ useful\\ for\\ evaluating\\ cortical\\ destruction\\,\\ sequestration\\,\\ cloacae\\,\\ and\\ bone\\ and\\ soft\\ tissue\\ abscesses\\,\\ \\ mr\\ imaging\\ \\(t1\\-weighted\\,\\ t2\\-weighted\\ with\\ fat\\ sat\\ and\\ post\\ contrast\\ sequences\\)\\ is\\ the\\ best\\ modality\\ for\\ evaluating\\ osteomyelitis\\,\\ cellulitis\\ and\\ areas\\ of\\ necrosis\\ for\\ debridement\\.\\ tc\\ 99m\\ \\â\\€\\“bone\\ scintigraphy\\ may\\ also\\ be\\ useful\\ for\\ diagnosing\\ osteomyelitis\\ but\\ does\\ not\\ have\\ the\\ resolution\\ of\\ mri\\.\\ \\ dual\\ isotope\\ bone\\-granulocyte\\ scintigraphy\\ \\(tc\\ 99m\\ mdpbone\\ and\\ white\\ blood\\ cells\\ labeled\\ with\\ indium\\-111\\)\\ has\\ a\\ high\\ sensitivity\\ \\(84\\%\\)\\ and\\ specificity\\ \\(71\\%\\)\\ in\\ detecting\\ areas\\ of\\ acute\\ infection\\.\\ however\\,\\ mri\\ has\\ increased\\ sensitivity\\ and\\ accuracy\\ in\\ the\\ detection\\ of\\ osteomyelitis\\ as\\ compared\\ to\\ three\\-phase\\ bone\\ scintigraphy\\.\\ \\ in\\ cases\\ of\\ acute\\ osteomyelitis\\,\\ the\\ process\\ is\\ identified\\ as\\ area\\(s\\)\\ of\\ low\\ signal\\ intensity\\ on\\ t1\\-weighted\\ images\\ and\\ high\\ signal\\ intensity\\ images\\ in\\ the\\ medullary\\ canal\\ on\\ fat\\-saturated\\ t2\\-weighted\\ \\ mr\\ images\\ or\\ stir\\ \\(short\\ tau\\ inversion\\ recovery\\)\\ mr\\ images\\.\\ cellulitis\\ shows\\ similar\\ findings\\ \\(low\\-signal\\-intensity\\ \\ foci\\ on\\ t1\\-weighted\\ images\\ and\\ high\\-signal\\-intensity\\ foci\\ on\\ fat\\-saturated\\ t2\\-weighted\\ or\\ stir\\ mr\\ images\\)\\.\\ contrast\\-enhanced\\ t1\\-weighted\\ \\ mr\\ imaging\\ shows\\ not\\ only\\ the\\ enhancement\\ of\\ areas\\ of\\ osteomyelitis\\ and\\ cellulitis\\,\\ but\\ also\\ shows\\ non\\-enhancing\\ areas\\ of\\ necrosis\\ important\\ for\\ debridement\\.\\ \\ active\\ and\\ inactive\\ phases\\ of\\ osteomyelitis\\ may\\ be\\ differentiated\\ by\\ \\ in\\ the\\ acute\\ phase\\ the\\ presence\\ of\\ periosteal\\ bone\\ formation\\ with\\ subperiosteal\\ fluid\\ and\\ areas\\ of\\ high\\ signal\\ intensity\\ areas\\ on\\ t2\\-weighted\\ and\\ stir\\ mr\\ images\\ that\\ enhance\\ after\\ contrast\\ media\\.\\ \\ bone\\ sclerosis\\ is\\ low\\ signal\\ intensity\\ on\\ mr\\ sequences\\.\\ abscesses\\ and\\ tracts\\ can\\ also\\ be\\ demonstrated\\ on\\ mri\\.\\ \\ for\\ definitive\\ histologic\\ diagnosis\\,\\ fluoroscopy\\ and\\/or\\ ct\\ is\\ used\\ to\\ biopsy\\ appendicular\\ and\\ axial\\ lesions\\ and\\ fluoroscopy\\ can\\ be\\ sometimes\\ use\\ for\\ biopsying\\ appendicular\\ lesions\\.\\ \\ \\ deep\\ abscesses\\ can\\ be\\ drained\\ with\\ ct\\ guidance\\ and\\ superficial\\ abscesses\\ with\\ sonographic\\ or\\ ct\\ guidance\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.08440661716276104\ \(0\)\
\-\ areas\\:\\ 0\\.030556292999426853\ \(0\)\
\-\ femur\\:\\ 0\\.027461085134901884\ \(0\)\
\-\ bone\\:\\ 0\\.02707886947664021\ \(0\)\
\-\ osteolysis\\:\\ 0\\.02625488244145054\ \(0\)\
\-\ knee\\:\\ 0\\.023049346501511088\ \(0\)\
\-\ acute\\:\\ 0\\.022421671935244372\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.021106783516499212\ \(0\)\
\-\ abscesses\\:\\ 0\\.020516617969828795\ \(0\)\
\-\ mr\\:\\ 0\\.020198083213204078\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.01992936892208887\ \(0\)\
\-\ may\\:\\ 0\\.01991847363334882\ \(0\)\
\-\ 99m\\:\\ 0\\.019265450696259456\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.018392697361251258\ \(0\)\
\-\ be\\:\\ 0\\.018204928165219\ \(0\)\
\-\ chronic\\:\\ 0\\.01790534264649203\ \(0\)\
\-\ stir\\:\\ 0\\.017717604312258287\ \(0\)\
\-\ medullary\\:\\ 0\\.01745372251925256\ \(0\)\
\-\ distal\\:\\ 0\\.0172826249974731\ \(0\)\
\-\ debridement\\:\\ 0\\.01686235249527206\ \(0\)\
\-\ cortical\\:\\ 0\\.016551938632177535\ \(0\)\
\-\ sequestrum\\:\\ 0\\.01640150081891262\ \(0\)\
\-\ cellulitis\\:\\ 0\\.016188678445323474\ \(0\)\
\-\ infection\\:\\ 0\\.01583857539260026\ \(0\)\
\-\ foci\\:\\ 0\\.015592025280140467\ \(0\)\
\-\ evaluating\\:\\ 0\\.015159645313772833\ \(0\)\
\-\ inactive\\:\\ 0\\.014316847783818622\ \(0\)\
\-\ images\\:\\ 0\\.013936356148347324\ \(0\)\
\-\ \\)\\:\\ 0\\.013648967543081288\ \(0\)\
\-\ fat\\-saturated\\:\\ 0\\.01364000669748805\ \(0\)\
\-\ destruction\\:\\ 0\\.013455043274703215\ \(0\)\
\-\ intensity\\:\\ 0\\.013129312120634647\ \(0\)\
\-\ tc\\:\\ 0\\.012714782316493691\ \(0\)\
\-\ dual\\:\\ 0\\.012369364825531365\ \(0\)\
\-\ can\\:\\ 0\\.012358484712873982\ \(0\)\
\-\ appendicular\\:\\ 0\\.012265666283194632\ \(0\)\
\-\ tracts\\:\\ 0\\.012166792711175732\ \(0\)\
\-\ deformity\\:\\ 0\\.011731307078372697\ \(0\)\
\-\ or\\:\\ 0\\.011707492283316454\ \(0\)\
\-\ guidance\\:\\ 0\\.011654227234412952\ \(0\)\
\-\ fluoroscopy\\:\\ 0\\.011579644195494204\ \(0\)\
\-\ radiograph\\:\\ 0\\.011570451238773061\ \(0\)\
\-\ \\(\\:\\ 0\\.01074714576770887\ \(0\)\
\-\ post\\-traumatic\\:\\ 0\\.010599101014829762\ \(0\)\
\-\ by\\:\\ 0\\.010584586952937432\ \(0\)\
\-\ changes\\:\\ 0\\.0104104058500959\ \(0\)\
\-\ sensitivity\\:\\ 0\\.010258308984914397\ \(0\)\
\-\ left\\:\\ 0\\.010160523584196756\ \(0\)\
\-\ on\\:\\ 0\\.010000619724495818\ \(0\)\
\-\ modality\\:\\ 0\\.009964684461044435\ \(0\)\
\-\ \\,\\:\\ 0\\.009781235098392956\ \(0\)\
\-\ signal\\:\\ 0\\.009577361658970366\ \(0\)\
\-\ useful\\:\\ 0\\.009476747284329238\ \(0\)\
\-\ eleveated\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ 99\\-m\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ 20\\-hour\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ tc\\-mdp\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ 111\\-in\\-wbc\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ asplenic\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ insufficiently\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ 10\\-21\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ involucra\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ cloacae\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ \\â\\€\\“bone\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ bone\\-granulocyte\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ mdpbone\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ biopsying\\:\\ 0\\.009368244871377787\ \(0\)\
\-\ characterized\\:\\ 0\\.009035430887351035\ \(0\)\
\-\ soft\\:\\ 0\\.008845597296465675\ \(0\)\
\-\ polymorphonucleated\\:\\ 0\\.008631637878221628\ \(0\)\
\-\ mononucleated\\:\\ 0\\.008631637878221628\ \(0\)\
\-\ contaminated\\:\\ 0\\.008631637878221628\ \(0\)\
\-\ periosteal\\:\\ 0\\.0086149723467986\ \(0\)\
\-\ area\\:\\ 0\\.008613718100321787\ \(0\)\
\-\ tissue\\:\\ 0\\.008609654361116232\ \(0\)\
\-\ reactive\\:\\ 0\\.008596883739640453\ \(0\)\
\-\ imaging\\:\\ 0\\.008510409455709257\ \(0\)\
\-\ days\\:\\ 0\\.008349864918720439\ \(0\)\
\-\ nonfatty\\:\\ 0\\.00820075040945631\ \(0\)\
\-\ microorganisms\\:\\ 0\\.00820075040945631\ \(0\)\
\-\ tau\\:\\ 0\\.00820075040945631\ \(0\)\
\-\ demonstrates\\:\\ 0\\.007934627849747867\ \(0\)\
\-\ sequestra\\:\\ 0\\.00789503088506547\ \(0\)\
\-\ isotope\\:\\ 0\\.00789503088506547\ \(0\)\
\-\ 3\\-phase\\:\\ 0\\.007657896399078\ \(0\)\
\-\ methylene\\:\\ 0\\.007657896399078\ \(0\)\
\-\ pathogen\\:\\ 0\\.007657896399078\ \(0\)\
\-\ sequences\\:\\ 0\\.007584472586197688\ \(0\)\
\-\ after\\:\\ 0\\.007515414251261222\ \(0\)\
\-\ shows\\:\\ 0\\.007490033049082504\ \(0\)\
\-\ same\\:\\ 0\\.007486107543553679\ \(0\)\
\-\ concordant\\:\\ 0\\.007464143416300152\ \(0\)\
\-\ osteosclerosis\\:\\ 0\\.007464143416300152\ \(0\)\
\-\ high\\:\\ 0\\.007455513478459561\ \(0\)\
\-\ trauma\\:\\ 0\\.007450612481693716\ \(0\)\
\-\ blood\\:\\ 0\\.007435954535098723\ \(0\)\
\-\ three\\-phase\\:\\ 0\\.007300327603518794\ \(0\)\
\-\ cells\\:\\ 0\\.00728256470595111\ \(0\)\
\-\ and\\:\\ 0\\.007269226586423274\ \(0\)\
\-\ canal\\:\\ 0\\.007215692719860174\ \(0\)\
\-\ is\\:\\ 0\\.007170551902887043\ \(0\)\
\-\ necrosis\\:\\ 0\\.0071691832379271085\ \(0\)\
\-\ also\\:\\ 0\\.0071609759560899095\ \(0\)\
\-\ evolve\\:\\ 0\\.007158423891909311\ \(0\)\
\-\ fistulous\\:\\ 0\\.007158423891909311\ \(0\)\
\-\ indium\\-111\\:\\ 0\\.007158423891909311\ \(0\)\
\-\ communicates\\:\\ 0\\.007033255947534833\ \(0\)\
\-\ process\\:\\ 0\\.006992700286577501\ \(0\)\
\-\ for\\:\\ 0\\.006973404184680591\ \(0\)\
\-\ weightbearing\\:\\ 0\\.006921289405921841\ \(0\)\
\-\ diphosphonate\\:\\ 0\\.006921289405921841\ \(0\)\
\-\ offending\\:\\ 0\\.006921289405921841\ \(0\)\
\-\ chronicity\\:\\ 0\\.006921289405921841\ \(0\)\
\-\ has\\:\\ 0\\.006821253859699374\ \(0\)\
\-\ low\\-signal\\-intensity\\:\\ 0\\.006820003348744025\ \(0\)\
\-\ c\\-reactive\\:\\ 0\\.006727536423143993\ \(0\)\
\-\ granulation\\:\\ 0\\.006727536423143993\ \(0\)\
\-\ in\\:\\ 0\\.006717277844956243\ \(0\)\
\-\ condyles\\:\\ 0\\.006642475097242253\ \(0\)\
\-\ begun\\:\\ 0\\.006642475097242253\ \(0\)\
\-\ high\\-signal\\-intensity\\:\\ 0\\.006642475097242253\ \(0\)\
\-\ presence\\:\\ 0\\.0065925305386974045\ \(0\)\
\-\ route\\:\\ 0\\.006563720610362635\ \(0\)\
\-\ including\\:\\ 0\\.0065577441891454275\ \(0\)\
\-\ the\\:\\ 0\\.006464366128543608\ \(0\)\
\-\ biopsy\\:\\ 0\\.0064435563052853565\ \(0\)\
\-\ aspirate\\:\\ 0\\.006421816898753152\ \(0\)\
\-\ periostitis\\:\\ 0\\.006421816898753152\ \(0\)\
\-\ metadiaphysis\\:\\ 0\\.006357391158246846\ \(0\)\
\-\ radiopharmaceutical\\:\\ 0\\.006357391158246846\ \(0\)\
\-\ distinguishing\\:\\ 0\\.006357391158246846\ \(0\)\
\-\ ct\\:\\ 0\\.0063512415164295585\ \(0\)\
\-\ staphylococcus\\:\\ 0\\.006296648954378675\ \(0\)\
\-\ labeled\\:\\ 0\\.006296648954378675\ \(0\)\
\-\ that\\:\\ 0\\.006274094489091704\ \(0\)\
\-\ mri\\:\\ 0\\.006259115371672539\ \(0\)\
\-\ vancomycin\\:\\ 0\\.00623919175855479\ \(0\)\
\-\ mdp\\:\\ 0\\.00623919175855479\ \(0\)\
\-\ organism\\:\\ 0\\.00623919175855479\ \(0\)\
\-\ give\\:\\ 0\\.006184682412765682\ \(0\)\
\-\ periosteum\\:\\ 0\\.006132833141597316\ \(0\)\
\-\ osteolytic\\:\\ 0\\.006132833141597316\ \(0\)\
\-\ subperiosteal\\:\\ 0\\.006132833141597316\ \(0\)\
\-\ walled\\:\\ 0\\.006083396355587866\ \(0\)\
\-\ accuracy\\:\\ 0\\.006083396355587866\ \(0\)\
\-\ anteroposterior\\:\\ 0\\.00603615750057104\ \(0\)\
\-\ persistence\\:\\ 0\\.00603615750057104\ \(0\)\
\-\ white\\:\\ 0\\.006023600877177508\ \(0\)\
\-\ aureus\\:\\ 0\\.005990929429987834\ \(0\)\
\-\ untreated\\:\\ 0\\.005990929429987834\ \(0\)\
\-\ indications\\:\\ 0\\.005990929429987834\ \(0\)\
\-\ detecting\\:\\ 0\\.005990929429987834\ \(0\)\
\-\ tracer\\:\\ 0\\.0059475479267782115\ \(0\)\
\-\ phases\\:\\ 0\\.0059475479267782115\ \(0\)\
\-\ specificity\\:\\ 0\\.005905868104086095\ \(0\)\
\-\ a\\:\\ 0\\.0059005284011269055\ \(0\)\
\-\ joint\\:\\ 0\\.00587338842729454\ \(0\)\
\-\ hematogenous\\:\\ 0\\.0058657614856133565\ \(0\)\
\-\ rise\\:\\ 0\\.0058657614856133565\ \(0\)\
\-\ drained\\:\\ 0\\.0058657614856133565\ \(0\)\
\-\ certain\\:\\ 0\\.005827113617206476\ \(0\)\
\-\ but\\:\\ 0\\.005810318706801926\ \(0\)\
\-\ diagnosing\\:\\ 0\\.005789822097747102\ \(0\)\
\-\ media\\:\\ 0\\.005789822097747102\ \(0\)\
\-\ bacteria\\:\\ 0\\.0057537949440003636\ \(0\)\
\-\ inversion\\:\\ 0\\.0057537949440003636\ \(0\)\
\-\ histologic\\:\\ 0\\.0057537949440003636\ \(0\)\
\-\ radiographs\\:\\ 0\\.005751904019558199\ \(0\)\
\-\ identification\\:\\ 0\\.005718949223678376\ \(0\)\
\-\ aid\\:\\ 0\\.005718949223678376\ \(0\)\
\-\ 84\\:\\ 0\\.005718949223678376\ \(0\)\
\-\ 82\\:\\ 0\\.005620784165090687\ \(0\)\
\-\ produces\\:\\ 0\\.005620784165090687\ \(0\)\
\-\ low\\-grade\\:\\ 0\\.0055600419612225165\ \(0\)\
\-\ windows\\:\\ 0\\.0055309250917346155\ \(0\)\
\-\ non\\-enhancing\\:\\ 0\\.0055309250917346155\ \(0\)\
\-\ as\\:\\ 0\\.005494484615915527\ \(0\)\
\-\ only\\:\\ 0\\.00546102371622728\ \(0\)\
\-\ fused\\:\\ 0\\.0054480754196095235\ \(0\)\
\-\ lucencies\\:\\ 0\\.0054480754196095235\ \(0\)\
\-\ diabetic\\:\\ 0\\.0054218345985783106\ \(0\)\
\-\ resolve\\:\\ 0\\.005371220306347434\ \(0\)\
\-\ sequestration\\:\\ 0\\.005371220306347434\ \(0\)\
\-\ detection\\:\\ 0\\.005276695879124803\ \(0\)\
\-\ 71\\:\\ 0\\.005254322436831676\ \(0\)\
\-\ contiguous\\:\\ 0\\.005232410335659799\ \(0\)\
\-\ indicative\\:\\ 0\\.005189896696325368\ \(0\)\
\-\ axial\\:\\ 0\\.005183403774852011\ \(0\)\
\-\ sat\\:\\ 0\\.005169261110929936\ \(0\)\
\-\ tend\\:\\ 0\\.005149018608304332\ \(0\)\
\-\ far\\:\\ 0\\.005129154492457199\ \(0\)\
\-\ contrast\\-enhanced\\:\\ 0\\.005090506624050317\ \(0\)\
\-\ low\\:\\ 0\\.005050304044349414\ \(0\)\
\-\ necrotic\\:\\ 0\\.00496533867967584\ \(0\)\
\-\ recovery\\:\\ 0\\.0049486029124408346\ \(0\)\
\-\ significant\\:\\ 0\\.004883840916162004\ \(0\)\
\-\ lesions\\:\\ 0\\.004861977696799039\ \(0\)\
\-\ differentiated\\:\\ 0\\.004853372138062847\ \(0\)\
\-\ superficial\\:\\ 0\\.004853372138062847\ \(0\)\
\-\ condyle\\:\\ 0\\.004838298137008696\ \(0\)\
\-\ accumulation\\:\\ 0\\.004838298137008696\ \(0\)\
\-\ culture\\:\\ 0\\.004838298137008696\ \(0\)\
\-\ differentiation\\:\\ 0\\.004838298137008696\ \(0\)\
\-\ insufficiency\\:\\ 0\\.004823434968066358\ \(0\)\
\-\ e\\.g\\:\\ 0\\.004808776814897032\ \(0\)\
\-\ source\\:\\ 0\\.004794318098578457\ \(0\)\
\-\ protein\\:\\ 0\\.004659619155284999\ \(0\)\
\-\ sometimes\\:\\ 0\\.004622327635825626\ \(0\)\
\-\ esr\\:\\ 0\\.004598174340312814\ \(0\)\
\-\ metaphysis\\:\\ 0\\.004517715443675518\ \(0\)\
\-\ definitive\\:\\ 0\\.004485014424901072\ \(0\)\
\-\ complication\\:\\ 0\\.0044532897031692095\ \(0\)\
\-\ increased\\:\\ 0\\.004443113245057717\ \(0\)\
\-\ replacement\\:\\ 0\\.004432654117773779\ \(0\)\
\-\ poorly\\:\\ 0\\.004432654117773779\ \(0\)\
\-\ sonographic\\:\\ 0\\.0044024331450633275\ \(0\)\
\-\ spread\\:\\ 0\\.00439254749930104\ \(0\)\
\-\ enhance\\:\\ 0\\.00439254749930104\ \(0\)\
\-\ systemic\\:\\ 0\\.004344453353086246\ \(0\)\
\-\ infections\\:\\ 0\\.004316608111434786\ \(0\)\
\-\ shift\\:\\ 0\\.0043074861733993\ \(0\)\
\-\ \\;\\:\\ 0\\.004304827180558116\ \(0\)\
\-\ visible\\:\\ 0\\.004298441869820226\ \(0\)\
\-\ direct\\:\\ 0\\.004289473890387851\ \(0\)\
\-\ involve\\:\\ 0\\.004280580957688047\ \(0\)\
\-\ appropriate\\:\\ 0\\.004280580957688047\ \(0\)\
\-\ short\\:\\ 0\\.004280580957688047\ \(0\)\
\-\ phase\\:\\ 0\\.0042717618261102624\ \(0\)\
\-\ predominantly\\:\\ 0\\.004254340136656833\ \(0\)\
\-\ \\%\\:\\ 0\\.004236601558652514\ \(0\)\
\-\ of\\:\\ 0\\.0042094890830304005\ \(0\)\
\-\ diagnosis\\:\\ 0\\.004170498046292072\ \(0\)\
\-\ off\\:\\ 0\\.00414757017877837\ \(0\)\
\-\ reaction\\:\\ 0\\.004124383093343046\ \(0\)\
\-\ important\\:\\ 0\\.004079473625447315\ \(0\)\
\-\ contrast\\:\\ 0\\.004065410598954103\ \(0\)\
\-\ sclerotic\\:\\ 0\\.004064915873738323\ \(0\)\
\-\ from\\:\\ 0\\.004037520870842334\ \(0\)\
\-\ marrow\\:\\ 0\\.0039949762153222\ \(0\)\
\-\ until\\:\\ 0\\.003988228895791213\ \(0\)\
\-\ difficult\\:\\ 0\\.003974861433297206\ \(0\)\
\-\ four\\:\\ 0\\.00394216041452276\ \(0\)\
\-\ not\\:\\ 0\\.003936722651674608\ \(0\)\
\-\ have\\:\\ 0\\.003932918338714329\ \(0\)\
\-\ causing\\:\\ 0\\.003923012162128841\ \(0\)\
\-\ had\\:\\ 0\\.003918915662573237\ \(0\)\
\-\ resolution\\:\\ 0\\.003916705323106721\ \(0\)\
\-\ infectious\\:\\ 0\\.003904202834711836\ \(0\)\
\-\ cortex\\:\\ 0\\.0038857206426694676\ \(0\)\
\-\ findings\\:\\ 0\\.003865753317300658\ \(0\)\
\-\ inflammation\\:\\ 0\\.0038615673471566556\ \(0\)\
\-\ osseous\\:\\ 0\\.0038556138343525427\ \(0\)\
\-\ linear\\:\\ 0\\.0038496934889227286\ \(0\)\
\-\ compared\\:\\ 0\\.0038438059433588442\ \(0\)\
\-\ and\\/or\\:\\ 0\\.0038379508362271016\ \(0\)\
\-\ limited\\:\\ 0\\.003832127812035151\ \(0\)\
\-\ recurrent\\:\\ 0\\.003832127812035151\ \(0\)\
\-\ defined\\:\\ 0\\.0038263365211025635\ \(0\)\
\-\ best\\:\\ 0\\.003820576619434828\ \(0\)\
\-\ mid\\:\\ 0\\.003797844217754363\ \(0\)\
\-\ an\\:\\ 0\\.0037672631167419653\ \(0\)\
\-\ formation\\:\\ 0\\.003748407431744913\ \(0\)\
\-\ thin\\:\\ 0\\.0037324266906561343\ \(0\)\
\-\ tissues\\:\\ 0\\.00372715273811402\ \(0\)\
\-\ delayed\\:\\ 0\\.0036960471246176192\ \(0\)\
\-\ initially\\:\\ 0\\.0036960471246176192\ \(0\)\
\-\ single\\:\\ 0\\.003680829214123732\ \(0\)\
\-\ visualized\\:\\ 0\\.0036758046219920143\ \(0\)\
\-\ deep\\:\\ 0\\.0036758046219920143\ \(0\)\
\-\ fibrous\\:\\ 0\\.0036708036750872186\ \(0\)\
\-\ extensive\\:\\ 0\\.003631621384111313\ \(0\)\
\-\ bony\\:\\ 0\\.003631621384111313\ \(0\)\
\-\ uptake\\:\\ 0\\.003607846359930087\ \(0\)\
\-\ use\\:\\ 0\\.0035892020351150932\ \(0\)\
\-\ similar\\:\\ 0\\.003561834876664068\ \(0\)\
\-\ marked\\:\\ 0\\.0035439739645318877\ \(0\)\
\-\ change\\:\\ 0\\.003539555250240003\ \(0\)\
\-\ previous\\:\\ 0\\.0035264082876443103\ \(0\)\
\-\ used\\:\\ 0\\.003483723864981893\ \(0\)\
\-\ active\\:\\ 0\\.0034671188512697985\ \(0\)\
\-\ based\\:\\ 0\\.003463007823875622\ \(0\)\
\-\ femoral\\:\\ 0\\.0034548331739041494\ \(0\)\
\-\ antibiotics\\:\\ 0\\.003410963185622211\ \(0\)\
\-\ occur\\:\\ 0\\.0034070633674617838\ \(0\)\
\-\ defect\\:\\ 0\\.0033993064041444488\ \(0\)\
\-\ laboratory\\:\\ 0\\.0033465374451159043\ \(0\)\
\-\ wbc\\:\\ 0\\.0033103877264355065\ \(0\)\
\-\ they\\:\\ 0\\.0032719937582224292\ \(0\)\
\-\ sclerosis\\:\\ 0\\.003261759015330866\ \(0\)\
\-\ identified\\:\\ 0\\.0032449171532266965\ \(0\)\
\-\ to\\:\\ 0\\.0031769147280562206\ \(0\)\
\-\ new\\:\\ 0\\.0031644930678008058\ \(0\)\
\-\ inflammatory\\:\\ 0\\.003149113649513309\ \(0\)\
\-\ does\\:\\ 0\\.003098428342597244\ \(0\)\
\-\ elevated\\:\\ 0\\.0030811013404453374\ \(0\)\
\-\ thickening\\:\\ 0\\.0030782407754445817\ \(0\)\
\-\ fever\\:\\ 0\\.0030725426424569246\ \(0\)\
\-\ although\\:\\ 0\\.0030668748996563267\ \(0\)\
\-\ possible\\:\\ 0\\.003058429563107409\ \(0\)\
\-\ first\\:\\ 0\\.003047272513056166\ \(0\)\
\-\ palpation\\:\\ 0\\.0030307535391583974\ \(0\)\
\-\ swelling\\:\\ 0\\.003025303787440098\ \(0\)\
\-\ cases\\:\\ 0\\.003025303787440098\ \(0\)\
\-\ along\\:\\ 0\\.003001119954153577\ \(0\)\
\-\ surrounding\\:\\ 0\\.0029852978367319503\ \(0\)\
\-\ showed\\:\\ 0\\.0029774742485905383\ \(0\)\
\-\ vascular\\:\\ 0\\.0029774742485905383\ \(0\)\
\-\ plain\\:\\ 0\\.0029492706829852117\ \(0\)\
\-\ several\\:\\ 0\\.002919333512988722\ \(0\)\
\-\ revealed\\:\\ 0\\.002914424962663223\ \(0\)\
\-\ medial\\:\\ 0\\.0029046753598193963\ \(0\)\
\-\ should\\:\\ 0\\.002895014390955154\ \(0\)\
\-\ between\\:\\ 0\\.0028783161915241695\ \(0\)\
\-\ post\\:\\ 0\\.002859548387962055\ \(0\)\
\-\ clinical\\:\\ 0\\.0027941655686142446\ \(0\)\
\-\ show\\:\\ 0\\.002787625860246149\ \(0\)\
\-\ fat\\:\\ 0\\.002761862192222777\ \(0\)\
\-\ some\\:\\ 0\\.002757628325044377\ \(0\)\
\-\ treated\\:\\ 0\\.0027182261807479906\ \(0\)\
\-\ demonstrated\\:\\ 0\\.002664633350113674\ \(0\)\
\-\ level\\:\\ 0\\.0026173103375631583\ \(0\)\
\-\ s\\:\\ 0\\.0026044289767423877\ \(0\)\
\-\ when\\:\\ 0\\.002600777085670569\ \(0\)\
\-\ two\\:\\ 0\\.002600777085670569\ \(0\)\
\-\ fluid\\:\\ 0\\.002580912969823436\ \(0\)\
\-\ through\\:\\ 0\\.0025791254180880644\ \(0\)\
\-\ following\\:\\ 0\\.0025773408681202424\ \(0\)\
\-\ weeks\\:\\ 0\\.0025773408681202424\ \(0\)\
\-\ she\\:\\ 0\\.002549188248091575\ \(0\)\
\-\ 4\\:\\ 0\\.0025302570724538205\ \(0\)\
\-\ however\\:\\ 0\\.0025285526626961426\ \(0\)\
\-\ y\\/o\\:\\ 0\\.0025150149094788953\ \(0\)\
\-\ been\\:\\ 0\\.0024705577996429235\ \(0\)\
\-\ enhancement\\:\\ 0\\.0024341007078884547\ \(0\)\
\-\ common\\:\\ 0\\.002376479502610411\ \(0\)\
\-\ patients\\:\\ 0\\.0023502386815791986\ \(0\)\
\-\ prior\\:\\ 0\\.0023316820108420437\ \(0\)\
\-\ over\\:\\ 0\\.0023120537621041048\ \(0\)\
\-\ consistent\\:\\ 0\\.002226671911616581\ \(0\)\
\-\ pain\\:\\ 0\\.0022180832466115507\ \(0\)\
\-\ surgery\\:\\ 0\\.0022050999621256906\ \(0\)\
\-\ 1\\:\\ 0\\.0021608144186606873\ \(0\)\
\-\ into\\:\\ 0\\.0021608144186606873\ \(0\)\
\-\ 3\\:\\ 0\\.002126435203726397\ \(0\)\
\-\ with\\:\\ 0\\.0021137842651733534\ \(0\)\
\-\ most\\:\\ 0\\.00209653043754312\ \(0\)\
\-\ posterior\\:\\ 0\\.0020931334205126976\ \(0\)\
\-\ well\\:\\ 0\\.0020542836907212017\ \(0\)\
\-\ present\\:\\ 0\\.00205101886708999\ \(0\)\
\-\ lateral\\:\\ 0\\.0019624527583682787\ \(0\)\
\-\ 2\\:\\ 0\\.0019554776796073814\ \(0\)\
\-\ multiple\\:\\ 0\\.0019126525010406683\ \(0\)\
\-\ surgical\\:\\ 0\\.0019088435390557422\ \(0\)\
\-\ female\\:\\ 0\\.0018669078336321292\ \(0\)\
\-\ treatment\\:\\ 0\\.001838062656324003\ \(0\)\
\-\ patient\\:\\ 0\\.00182059921555024\ \(0\)\
\-\ which\\:\\ 0\\.0016951589662513801\ \(0\)\
\-\ normal\\:\\ 0\\.0014236051589788534\ \(0\)\
\-\ \\.\\:\\ 0\\.001395837232307983\ \(0\)\
\-\ history\\:\\ 0\\.0012542131112721396\ \(0\)\
\-\ at\\:\\ 0\\.0012303540412663475\ \(0\)\
